Shares of Edenred (OTCMKTS:EDNMY – Get Free Report) have earned a consensus recommendation of “Hold” from the eight research firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, two have given a buy rating and one has issued a strong buy rating on the company.
Several research firms have issued reports on EDNMY. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Edenred in a research note on Monday, August 3rd. Citigroup restated a “neutral” rating on shares of Edenred in a research note on Thursday, July 30th. Zacks Research lowered shares of Edenred from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 28th. Finally, Jefferies Financial Group reaffirmed a “hold” rating on shares of Edenred in a research report on Wednesday, June 10th.
View Our Latest Stock Report on Edenred
Edenred Stock Performance
Edenred Company Profile
Edenred is a global leader in prepaid corporate services, offering a suite of digital and paper-based solutions designed to enhance employee benefits, streamline expense management and support corporate fleets. The company originated in 1962 as part of the Accor group and was listed as an independent entity on Euronext Paris in 2010. Today, Edenred operates under the Ticket Restaurant® brand, which remains a flagship offering for meal voucher programs, alongside a host of other employee engagement and incentive tools.
The company’s core products and services include employee benefits such as meal vouchers, food allowances and leisure gift certificates, as well as incentive and rewards programs that help organizations motivate and recognize their workforce.
Further Reading
- Five stocks we like better than Edenred
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Edenred Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edenred and related companies with MarketBeat.com's FREE daily email newsletter.
